Impact of Photobiomodulation on T3/T4 Ratio and Quality of Life in Hashimoto Thyroiditis
Date
2020Author
Sahbaz, Nuri Alper
Erbil, Yesim
Acar, Sami
Tutal, Firat
Ercetin, Candas
Metadata
Show full item recordAbstract
Objective and background: Hashimoto's thyroiditis (HT) is both a B cell- and T cell-mediated, organ-specific autoimmune disease. No current treatment for underlying pathological mechanisms is available for HT and once diagnosed it requires long-term levothyroxine (LT4) treatment in most patients. The aim of our study was to evaluate the effects of photobiomodulation (PBM) on HT patients regarding thyroid functions, thyroid autoantibody levels, and decrease in hormone replacement needs.
Collections
- Makale [92796]